MedTrace Logo

Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis

NCT03691818 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 353

Last updated 2020-01-13

No results posted yet for this study

Summary

This study is a randomized, double-blind clinical trial in a Chinese population.

Conditions

Interventions

DRUG

X0002 Spray

According to the different dose groups assigned, each knee joint was sprayed with 1, 2 or 4 sprays.

DRUG

Ibuprofen Tablet

Ibuprofen Tab 400mg, tid.

DRUG

Ibuprofen Placebo Tab

Ibuprofen Placebo Tab 400mg, tid.

DRUG

X0002 Placebo Spray

According to the different dose groups assigned, each knee joint was sprayed with 1, 2 or 4 sprays.

Sponsors & Collaborators

  • Tianjin XinChen-Techfields Pharma Co., LTD.

    lead INDUSTRY

Principal Investigators

  • Zeng Xiaofeng · lead institution

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-16
Primary Completion
2019-10-21
Completion
2019-10-21

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03691818 on ClinicalTrials.gov